Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phantom hCG and phantom choriocarcinoma

L A Cole1

  • 1Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut, 06520, USA.

Gynecologic Oncology
|November 25, 1998
PubMed
Summary

Phantom hCG, a substance mimicking pregnancy hormone levels, can lead to misdiagnosis of choriocarcinoma. Proper laboratory testing, including dilution parallelism and urine analysis, is crucial to identify this phantom hCG and avoid unnecessary chemotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

hCG physiology.

Placenta·2013
Same author

First-trimester hyperglycosylated human chorionic gonadotropin and development of hypertension.

Prenatal diagnosis·2013
Same author

Hyperglycosylated hCG, a review.

Placenta·2010
Same author

Hyperglycosylated hCG.

Placenta·2007
Same author

HCG urinary metabolites in breast milk.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2004
Same author

Hyperglycosylated hCG cannot be measured using a sialic acid-specific lectin immunoassay.

Prenatal diagnosis·2003

Area of Science:

  • Reproductive Endocrinology
  • Clinical Chemistry
  • Oncology

Background:

  • Phantom human chorionic gonadotropin (hCG) syndrome, or pseudohypergonadotropinemia, involves persistent mild hCG elevations.
  • This can lead to misdiagnosis of choriocarcinoma and unnecessary cytotoxic chemotherapy.
  • Three cases of phantom hCG syndrome referred to the hCG Reference Service are presented.

Purpose of the Study:

  • To report and analyze three cases of phantom hCG syndrome.
  • To highlight the diagnostic challenges and implications of pseudohypergonadotropinemia.
  • To emphasize the importance of specific laboratory testing to differentiate phantom hCG from true trophoblast disease.

Main Methods:

  • Analysis of serum and urine samples from three patients with persistent low hCG levels.
  • Utilized multiple hCG assays, including assessment of dilutional parallelism.
  • Investigated presence of hCG, free beta-subunit, and beta-core fragment in serum and urine.

Main Results:

  • In all three cases, phantom hCG was diagnosed due to lack of dilutional parallelism and absence of urine hCG.
  • Patients presented with persistent low serum hCG levels after miscarriage or normal pregnancy.
  • Misdiagnosis of choriocarcinoma led to unnecessary chemotherapy and hysterectomy in one case.

Conclusions:

  • Persistent low hCG levels without a history of trophoblast disease require careful interpretation.
  • Dilutional parallelism and urine hCG testing are critical to exclude phantom hCG.
  • Accurate laboratory diagnostics are essential to prevent misdiagnosis and inappropriate treatment of choriocarcinoma.

Related Experiment Videos